Piribedil

Piribedil

SCHEMBL5605887

c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1.c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
USP2 O75604 1/20 1.00
CYP1A2 P05177 1/20 1.00
CYP3A4 P08684 1/20 1.00
HTR1A P08908 1/20 1.00
ADRA2A P08913 1/20 1.00
CYP2D6 P10635 1/20 1.00
DRD2 P14416 1/20 1.00
ADRA2B P18089 1/20 1.00
ADRA2C P18825 1/20 1.00
NFKB1 P19838 1/20 1.00
SLC6A2 P23975 1/20 1.00
MAPK1 P28482 1/20 1.00
SLC6A4 P31645 1/20 1.00
CYP2C19 P33261 1/20 1.00
ADRA1A P35348 1/20 1.00
DRD3 P35462 1/20 1.00
HTR2B P41595 1/20 1.00
KCNH2 Q12809 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piribedil SCHEMBL29359749 1.00 MEN1 (1.00) MEN1KMT2AUSP2CYP1A2CYP3A4
Piribedil SCHEMBL150101 1.00 MEN1 (1.00) MEN1KMT2AUSP2CYP1A2CYP3A4
Piribedil SCHEMBL27036877 0.99 MEN1 (0.97) MEN1KMT2AUSP2CYP1A2CYP3A4
Piribedil SCHEMBL14973600 0.99 MEN1 (0.97) MEN1KMT2AUSP2CYP1A2CYP3A4
Piribedil SCHEMBL3765569 0.99 MEN1 (0.97) MEN1KMT2AUSP2CYP1A2CYP3A4
Piribedil SCHEMBL28260221 0.94 MEN1 (0.88) MEN1KMT2AUSP2CYP1A2CYP3A4
SCHEMBL23652830 0.92 MEN1 (0.85) MEN1KMT2AUSP2CYP1A2CYP3A4
Piribedil SCHEMBL1652330 0.91 MAPK1 (0.82) MEN1KMT2AUSP2CYP1A2CYP3A4
Piribedil SCHEMBL1320656 0.90 LMNA (1.00) MEN1KMT2AUSP2CYP1A2CYP3A4
Piribedil SCHEMBL1320658 0.90 LMNA (1.00) MEN1KMT2AUSP2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3137065-A2 COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES Pharnext (FR) 2017-03-08 EP disclosed
WO-2015165948-A2 COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES PHARNEXT (FR) 2015-11-05 WO disclosed
EP-1742624-A2 DOPAMINE-AGONIST COMBINATION THERAPY WITH SEDATIVES FOR IMPROVING SLEEP QUALITY Sepracor, Inc. (US) 2007-01-17 EP disclosed
WO-2005079851-A2 DOPAMINE-AGONIST COMBINATION THERAPY WITH SEDATIVES FOR IMPROVING SLEEP QUALITY SEPRACOR, INC. (US) 2005-09-01 WO disclosed